Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01732614 · ClinicalTrials.gov registry record · NA
Topcon Endpoint Management
A NA study, sponsored by Retinal Consultants of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01732614: Completed NA study, sponsored by Retinal Consultants of Arizona.
NCT01732614 is a NA study that has completed, run by Retinal Consultants of Arizona. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01732614, a NA study, has completed, sponsored by Retinal Consultants of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This trial seeks to prove that sub-lethal laser power levels are as effective and less damaging than traditional laser. Diabetic macular edema (DME) affects approximately 29% of diabetic patients with a disease duration of 20 or more years and is one of the most frequent causes of vision loss in this population. The Early Treatment Diabetic Retinopathy Study (ETDRS) demonstrated a significant benefit of laser photocoagulation for the treatment of clinically significant macular edema, reducing the incidence of vision loss by approximately 50% at 3 years' follow-up.
Primary Outcome
Improvement in visual acuity \> 10 letters or two lines in the ETDRS chart
Interventions
- PROCEDURE Topcon Endpoint Management laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01732614 record still lists
NCT01732614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Topcon Endpoint Management laser is the first listed.
NCT01732614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01732614 about?
NCT01732614 is a clinical study titled "Topcon Endpoint Management". This trial seeks to prove that sub-lethal laser power levels are as effective and less damaging than traditional laser. Diabetic macular edema (DME) affects approximately 29% of diabetic patients with a disease duration of 20 or more years and is one of the most frequent causes of vision loss in thi...
What is the current status of trial NCT01732614?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2012-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01732614?
The interventions under investigation include: Topcon Endpoint Management laser (PROCEDURE).
Who is sponsoring clinical trial NCT01732614?
This trial is sponsored by Retinal Consultants of Arizona, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01732614's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia